DK0907632T3 - Inhibering af matrixmetalloproteaser med substituerede phenethyl-forbindelser - Google Patents
Inhibering af matrixmetalloproteaser med substituerede phenethyl-forbindelserInfo
- Publication number
- DK0907632T3 DK0907632T3 DK97923621T DK97923621T DK0907632T3 DK 0907632 T3 DK0907632 T3 DK 0907632T3 DK 97923621 T DK97923621 T DK 97923621T DK 97923621 T DK97923621 T DK 97923621T DK 0907632 T3 DK0907632 T3 DK 0907632T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibition
- matrix metalloproteases
- substituted phenethyl
- compounds
- phenethyl compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
- C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/88—Unsaturated compounds containing keto groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64502696A | 1996-05-15 | 1996-05-15 | |
| PCT/US1997/007919 WO1997043247A1 (en) | 1996-05-15 | 1997-05-12 | Inhibition of matrix metalloproteases by substituted phenethyl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0907632T3 true DK0907632T3 (da) | 2003-04-07 |
Family
ID=24587359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97923621T DK0907632T3 (da) | 1996-05-15 | 1997-05-12 | Inhibering af matrixmetalloproteaser med substituerede phenethyl-forbindelser |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0907632B1 (es) |
| JP (1) | JP3305328B2 (es) |
| CN (1) | CN1124255C (es) |
| AR (1) | AR007100A1 (es) |
| AT (1) | ATE229497T1 (es) |
| AU (1) | AU727899B2 (es) |
| BR (1) | BR9709084A (es) |
| CA (1) | CA2253870C (es) |
| CO (1) | CO5070565A1 (es) |
| DE (1) | DE69717811T2 (es) |
| DK (1) | DK0907632T3 (es) |
| ES (1) | ES2188943T3 (es) |
| HN (1) | HN1997000071A (es) |
| HR (1) | HRP970243B1 (es) |
| ID (1) | ID17424A (es) |
| PA (1) | PA8429801A1 (es) |
| PE (1) | PE66298A1 (es) |
| PT (1) | PT907632E (es) |
| SV (1) | SV1997000037A (es) |
| TN (1) | TNSN97082A1 (es) |
| TW (1) | TW363056B (es) |
| WO (1) | WO1997043247A1 (es) |
| YU (1) | YU18497A (es) |
| ZA (1) | ZA974029B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6288063B1 (en) * | 1998-05-27 | 2001-09-11 | Bayer Corporation | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors |
| JP2002534404A (ja) | 1998-12-30 | 2002-10-15 | バイエル アクチェンゲゼルシャフト | 呼吸器疾患の治療のためのマトリックスメタロプロテアーゼ阻害剤としての置換４−ビアリール酪酸および５−ビアリールペンタン酸誘導体の使用 |
| EP1031349A1 (en) * | 1999-02-25 | 2000-08-30 | Bayer Aktiengesellschaft | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
| US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
| FR2901320B1 (fr) * | 2006-05-17 | 2008-07-04 | Univ Savoie Etablissement Publ | Dispositif miniaturise apte a fonctionner comme moteur ou refroidisseur selon un cycle thermodynamique de stirling |
| EP3126339A1 (de) | 2014-04-03 | 2017-02-08 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituierte cyclopentancarbonsäuren und ihre verwendung |
| EP3126358A1 (de) | 2014-04-03 | 2017-02-08 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituierte cyclopentancarbonsäuren zur behandlung von atemwegserkrankungen |
| JP2017511319A (ja) | 2014-04-03 | 2017-04-20 | バイエル ファーマ アクチエンゲゼルシャフト | キラル２，５−ジ置換されたシクロペンタンカルボン酸誘導体およびそれの使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3784701A (en) * | 1970-09-21 | 1974-01-08 | American Cyanamid Co | Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain |
| DE2112716A1 (de) * | 1971-03-17 | 1972-10-05 | Thomae Gmbh Dr K | Neue 4-(4-Biphenylyl)-4-oxobuttersaeuren,ihre Salze und ihre Ester |
| US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
-
1997
- 1997-05-09 HR HR970243A patent/HRP970243B1/xx not_active IP Right Cessation
- 1997-05-09 ZA ZA9704029A patent/ZA974029B/xx unknown
- 1997-05-09 CO CO97025183A patent/CO5070565A1/es unknown
- 1997-05-09 TN TNTNSN97082A patent/TNSN97082A1/fr unknown
- 1997-05-12 DE DE69717811T patent/DE69717811T2/de not_active Expired - Fee Related
- 1997-05-12 YU YU18497A patent/YU18497A/sr unknown
- 1997-05-12 JP JP54097997A patent/JP3305328B2/ja not_active Expired - Fee Related
- 1997-05-12 SV SV1997000037A patent/SV1997000037A/es not_active Application Discontinuation
- 1997-05-12 AU AU29385/97A patent/AU727899B2/en not_active Ceased
- 1997-05-12 EP EP97923621A patent/EP0907632B1/en not_active Expired - Lifetime
- 1997-05-12 AT AT97923621T patent/ATE229497T1/de not_active IP Right Cessation
- 1997-05-12 HN HN1997000071A patent/HN1997000071A/es unknown
- 1997-05-12 DK DK97923621T patent/DK0907632T3/da active
- 1997-05-12 PA PA19978429801A patent/PA8429801A1/es unknown
- 1997-05-12 ES ES97923621T patent/ES2188943T3/es not_active Expired - Lifetime
- 1997-05-12 WO PCT/US1997/007919 patent/WO1997043247A1/en active IP Right Grant
- 1997-05-12 PE PE1997000366A patent/PE66298A1/es not_active Application Discontinuation
- 1997-05-12 AR ARP970101980A patent/AR007100A1/es unknown
- 1997-05-12 CN CN97196457A patent/CN1124255C/zh not_active Expired - Fee Related
- 1997-05-12 CA CA002253870A patent/CA2253870C/en not_active Expired - Fee Related
- 1997-05-12 TW TW086106288A patent/TW363056B/zh active
- 1997-05-12 BR BR9709084A patent/BR9709084A/pt not_active Application Discontinuation
- 1997-05-12 PT PT97923621T patent/PT907632E/pt unknown
- 1997-05-14 ID IDP971605A patent/ID17424A/id unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP970243B1 (en) | 2002-06-30 |
| DE69717811T2 (de) | 2003-05-28 |
| AU2938597A (en) | 1997-12-05 |
| SV1997000037A (es) | 1999-01-14 |
| CN1124255C (zh) | 2003-10-15 |
| WO1997043247A1 (en) | 1997-11-20 |
| ATE229497T1 (de) | 2002-12-15 |
| CA2253870A1 (en) | 1997-11-20 |
| TNSN97082A1 (fr) | 2005-03-15 |
| AR007100A1 (es) | 1999-10-13 |
| HRP970243A2 (en) | 1998-04-30 |
| ZA974029B (en) | 1998-02-19 |
| EP0907632A1 (en) | 1999-04-14 |
| YU18497A (en) | 1999-11-22 |
| PA8429801A1 (es) | 2000-05-24 |
| CA2253870C (en) | 2004-01-06 |
| CN1225624A (zh) | 1999-08-11 |
| BR9709084A (pt) | 1999-08-03 |
| CO5070565A1 (es) | 2001-08-28 |
| JPH11510517A (ja) | 1999-09-14 |
| PT907632E (pt) | 2003-04-30 |
| HN1997000071A (es) | 1997-06-18 |
| EP0907632B1 (en) | 2002-12-11 |
| JP3305328B2 (ja) | 2002-07-22 |
| ES2188943T3 (es) | 2003-07-01 |
| PE66298A1 (es) | 1998-10-23 |
| DE69717811D1 (en) | 2003-01-23 |
| ID17424A (id) | 1997-12-24 |
| TW363056B (en) | 1999-07-01 |
| AU727899B2 (en) | 2001-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0923585T3 (da) | Phosphinatbaserede inhibitorer af matrixmetalloproteinaser | |
| MA24215A1 (fr) | Composes inhibiteurs de squalene-synthetase | |
| DK0946510T3 (da) | Hidtil ukendte forbindelser med analgetisk virkning | |
| DE69736445D1 (de) | Refluxinhibitoren | |
| BR9711151A (pt) | Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida | |
| ID24638A (id) | Senyawa-senyawa anti aritmia bispidina | |
| NO991822L (no) | Substituerte tricykliske forbindelser | |
| DK1107980T3 (da) | Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH | |
| NO20003256D0 (no) | ACE inhibitor-MMP inhibitor kombinasjoner | |
| DK0839806T3 (da) | Substituerede tricykliske forbindelser | |
| DK0923530T3 (da) | Inhibering af matrixmetalloproteaser med substituerede biaryloxosmörsyrer | |
| BR9707514A (pt) | Inibidor de neovascularizacão | |
| LV12207A (lv) | Tricikliski savienojumi | |
| NO991823D0 (no) | Substituerte tricykliske forbindelser | |
| DK0907632T3 (da) | Inhibering af matrixmetalloproteaser med substituerede phenethyl-forbindelser | |
| NO20002696D0 (no) | Nye forbindelser med cGMP-PDE-inhibitoreffekt | |
| DE69714228D1 (de) | Kristalline metallophosphate | |
| IS5821A (is) | Kristalluð form af ósanetant | |
| BR9704110A (pt) | Medidor de água composto | |
| ATE224350T1 (de) | Inhibition der matrix metalloproteasen durch 2- (omega-aroylalkyl)-4-biaryl-4-oxobutansäuren | |
| DK1019042T3 (da) | Forbindelser med anti-første-passagevirkning | |
| FI944396A0 (fi) | Kiraalinen polarisaatiomuunnin | |
| DK1131313T3 (da) | Enantioselektiv alkylering af tricykliske forbindelser | |
| FI930223A0 (fi) | Lietteen levittimen jakolaite | |
| DK0923293T3 (da) | Behandling af diarré |